• Issue

    Liver International: Volume 38, Issue 9

    1515-1699
    September 2018
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1515-1519
  • First Published: 25 August 2018

REVIEWS

Free Access

Novel and emerging therapies for cholestatic liver diseases

Jordan Goldstein,  Cynthia Levy, 
  • Pages: 1520-1535
  • First Published: 14 May 2018
Free Access

Hepatitis E virus in South America: The current scenario

María B. Pisano,  Maribel G. Martinez-Wassaf,  Santiago Mirazo,  Anabella Fantilli,  Juan Arbiza,  José D. Debes,  Viviana E. Ré, 
  • Pages: 1536-1546
  • First Published: 22 May 2018

EDITORIALS

Free Access

The complex role of bone morphogenetic protein 9 in liver damage and regeneration: New evidence from in vivo and in vitro studies

Rosa M. Pascale,  Francesco Feo,  Diego F. Calvisi, 
  • Pages: 1547-1549
  • First Published: 25 August 2018

See Article on Page 1664

Free Access

Guidelines are silver, but a multidisciplinary team discussion may be golden?

Marcus-Alexander Wörns,  Peter R. Galle, 
  • Pages: 1550-1551
  • First Published: 25 August 2018

See Article on Page 1624

VIRAL HEPATITIS

Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection

Yasuhiro Asahina,  Yoshito Itoh,  Yoshiyuki Ueno,  Yasushi Matsuzaki,  Yasuhiro Takikawa,  Hiroshi Yatsuhashi,  Takuya Genda,  Fusao Ikeda,  Takuma Matsuda,  Hadas Dvory-Sobol,  Deyuan Jiang,  Benedetta Massetto,  Anu O. Osinusi,  Diana M. Brainard,  John G. McHutchison,  Norifumi Kawada,  Nobuyuki Enomoto, 
  • Pages: 1552-1561
  • First Published: 03 January 2018

Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients

Minhui Dong,  Jingwen Wu,  Xueping Yu,  Jing Li,  Sisi Yang,  Xun Qi,  Richeng Mao,  Yongmei Zhang,  Jie Yu,  Haoxiang Zhu,  Feifei Yang,  Yanli Qin,  Jiming Zhang, 
  • Pages: 1562-1570
  • First Published: 03 January 2018
Open Access

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin

Jordan J. Feld,  David E. Bernstein,  Ziad Younes,  Hans Van Vlierberghe,  Lois Larsen,  Fernando Tatsch,  Peter Ferenci, 
  • Pages: 1571-1575
  • First Published: 27 January 2018

Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population

Suhg Namgoong,  Joong-Gon Shin,  Hyun Sub Cheong,  Lyoung Hyo Kim,  Ji On Kim,  Jung Yeon Seo,  Hyoung Doo Shin,  Yoon Jun Kim, 
  • Pages: 1576-1582
  • First Published: 28 December 2017

Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis

Tarik Asselah,  Hendrik Reesink,  Jan Gerstoft,  Victor de Ledinghen,  Paul J. Pockros,  Michael Robertson,  Peggy Hwang,  Ernest Asante-Appiah,  Janice Wahl,  Bach-Yen Nguyen,  Eliav Barr,  Rohit Talwani,  Lawrence Serfaty, 
  • Pages: 1583-1591
  • First Published: 20 February 2018

CIRRHOSIS AND LIVER FAILURE

Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure

Abigail Zabron,  Alberto Quaglia,  Evangelia Fatourou,  Praveen Peddu,  Dylan Lewis,  Michael Heneghan,  Christopher Willars,  Georg Auzinger,  Nigel Heaton,  Julia Wendon,  Pauline Kane,  John Karani,  William Bernal, 
  • Pages: 1592-1601
  • First Published: 20 February 2018

Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis

Tammo L. Tergast,  Anika Wranke,  Hans Laser,  Svetlana Gerbel,  Michael. P. Manns,  Markus Cornberg,  Benjamin Maasoumy, 
  • Pages: 1602-1613
  • First Published: 19 April 2018

Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome

Signe Wiese,  Jens Hove,  Silje Mo,  Rajeshwar P. Mookerjee,  Claus L. Petersen,  Marianne K. Vester-Andersen,  Naja D. Mygind,  Jens P. Goetze,  Andreas Kjær,  Flemming Bendtsen,  Søren Møller, 
  • Pages: 1614-1623
  • First Published: 30 April 2018

CANCER

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

Angelo Sangiovanni,  Michela Triolo,  Massimo Iavarone,  Laura V. Forzenigo,  Antonio Nicolini,  Giorgio Rossi,  Vincenzo La Mura,  Massimo Colombo,  Pietro Lampertico, 
  • Pages: 1624-1634
  • First Published: 23 May 2018

See Editorial on Page 1550

Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patients

Masashi Kumagai,  Eishiro Mizukoshi,  Toshikatsu Tamai,  Masaaki Kitahara,  Tatsuya Yamashita,  Kuniaki Arai,  Takeshi Terashima,  Noriho Iida,  Kazumi Fushimi,  Shuichi Kaneko, 
  • Pages: 1635-1645
  • First Published: 06 February 2018

Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein

Jin Hyoung Kim,  Ju Hyun Shim,  Hyun-Ki Yoon,  Heung-Kyu Ko,  Jong Woo Kim,  Dong Il Gwon, 
  • Pages: 1646-1654
  • First Published: 13 February 2018

Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib

Mi Young Jeon,  Hye Won Lee,  Beom Kyung Kim,  Jun Yong Park,  Do Young Kim,  Sang Hoon Ahn,  Kwang-Hyub Han,  Song-Ee Baek,  Hye Soo Kim,  Seung Up Kim,  Mi Suk Park, 
  • Pages: 1655-1663
  • First Published: 01 March 2018

AUTOIMMUNE AND CHOLESTATIC LIVER DISEASE

Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury

Annalisa Addante,  Cesáreo Roncero,  Laura Almalé,  Nerea Lazcanoiturburu,  María García-Álvaro,  Margarita Fernández,  Julián Sanz,  Seddik Hammad,  Zeribe C. Nwosu,  Se-Jin Lee,  Isabel Fabregat,  Steven Dooley,  Peter ten Dijke,  Blanca Herrera,  Aránzazu Sánchez, 
  • Pages: 1664-1675
  • First Published: 11 May 2018

See Editorial on Page 1547

Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations

Teng Liu,  Ren-Xue Wang,  Jun Han,  Chen-Zhi Hao,  Yi-Ling Qiu,  Yan-Yan Yan,  Li-Ting Li,  Neng-Li Wang,  Jing-Yu Gong,  Yi Lu,  Mei-Hong Zhang,  Xin-Bao Xie,  Jun-Cong Yang,  Yi-Jie You,  Jia-qi Li,  A. S. Knisely,  Christoph H. Borchers,  Victor Ling,  Jian-She Wang, 
  • Pages: 1676-1685
  • First Published: 07 February 2018

Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK

Victoria Gordon,  Ratul Adhikary,  Victoria Appleby,  Debasis Das,  James Day,  Toby Delahooke,  Selena Dixon,  David Elphick,  Claire Hardie,  Barbara Hoeroldt,  Patricia Hooper,  John Hutchinson,  Rebecca Jones,  Faisal Khan,  Guruprasad P. Aithal,  John McGonigle,  Andrew Nelson,  Alick Nkhoma,  Stavroula Pelitari,  Martin Prince,  Annell Prosser,  Vinay Sathanarayana,  Sophia Savva,  Naina Shah,  Sushma Saksena,  Sreedhari Thayalasekaran,  Deven Vani,  Andrew Yeoman,  Dermot Gleeson,  The UK Multi-Centre AIH Audit Group , 
  • Pages: 1686-1695
  • First Published: 17 February 2018

LIVER INTERNATIONAL IMAGES

Hepatitis E-induced acute-on-chronic liver failure and VI nerve paralysis

Gerhard Jung,  Pol Olivas,  Alba Díaz,  Sabela Lens, 
  • Pages: 1696-1697
  • First Published: 09 June 2018

LETTERS TO THE EDITOR

Post-paracentesis hemoperitoneum — Time to become more careful!

Sandeep Satsangi, 
  • Page: 1698
  • First Published: 17 February 2018

Author response to Letter to the Editor “Post-paracentesis hemoperitoneum - time to become more careful!”

Adelina Hung,  Guadalupe Garcia-Tsao, 
  • Pages: 1698-1699
  • First Published: 25 August 2018